Atkinson Edward Morrow III
- SEC CIK
- 0001914164
In the past year, 4 open-market sale filings worth $3.60M and no purchases.
Current role at each company
- VRTX Vertex Pharmaceuticals IncEVP, Chief Technical Ops. Off.as of Feb 26, 2026
- ETNB 89bio, Inc.Directoras of Oct 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.60M
- 4 filings
- Net
- −$3.60M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Atkinson Edward Morrow III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, Chief Technical Ops. Off.12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 (view filing) | Feb 25 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −668 | $486.35 | −$324.9K | −3.5%18.4K after | 10b5-1 |
| Feb 19, 2026 (view filing) | Feb 17-18 | 2 days | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −2.85K | $484.93 | −$1.38M | −12.1%20.7K after | 2 lots10b5-1 |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −1.75K | $460.43 | −$806.2K | −7.4%22.0K after | 10b5-1 |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −2.50K | $434.58 | −$1.09M | −12.9%16.9K after | 10b5-1 |
| Feb 28, 2025 (view filing) | Feb 27 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −2.65K | $475.34 | −$1.26M | −12.0%19.4K after | 10b5-1 |
| Feb 26, 2025 (view filing) | Feb 25 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −1.77K | $480.95 | −$849.8K | −6.7%24.5K after | 10b5-1 |
| Feb 12, 2025 (view filing) | Feb 11 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −1.75K | $459.83 | −$803.3K | −7.0%23.2K after | 10b5-1 |
| Jun 13, 2024 (view filing) | Jun 12 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −7.29K | $478.00 | −$3.48M | −31.3%16.0K after | 10b5-1 |
| Feb 27, 2024 (view filing) | Feb 26 | 1 day | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −883 | $425.70 | −$375.9K | −5.2%16.0K after | 10b5-1 |
| Feb 23, 2024 (view filing) | Feb 21 | 2 days | Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | SSale | −1.20K | $421.77 | −$506.5K | −6.1%18.5K after | 10b5-1 |
ETNB 89bio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing) | Jun 1 | 4 days | Atkinson Edward Morrow IIIDirector | SSale | −6.25K | $17.91 | −$111.9K | −100.0%0 after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Atkinson Edward Morrow IIIDirector | SSale | −10.0K | $13.60 | −$136.0K | −100.0%0 after |